ATProto Browser

Record data

{
  "uri": "at://did:plc:n4e5fq6pc5ikcibo4ejgmlsm/app.bsky.feed.post/3lmzolyxwtc2j",
  "cid": "bafyreiarqgopyky7g7b5ww5gmb2bfmdkuiftvyb4b6pt6mod6zwhpwdkhe",
  "value": {
    "text": "Review: Pyridostigmin (Mestinon) kann bei neurogener orthostatischer Hypotension ein sinnvoller Therapieversuch sein, auch in Kombination mit anderen Medikamenten.\n\nFür #MECFS wurde das nirgends untersucht, aber neurogene oH kommt auch hier vor.\n\nopenheart.bmj.com/content/12/1...",
    "$type": "app.bsky.feed.post",
    "embed": {
      "$type": "app.bsky.embed.external",
      "external": {
        "uri": "https://openheart.bmj.com/content/12/1/e003106",
        "thumb": {
          "$type": "blob",
          "ref": {
            "$link": "bafkreibjm5j2wm7getztytw2n2ws4cttrmjzkkco5ifjfsjzmgwezj3i4i"
          },
          "mimeType": "image/jpeg",
          "size": 837897
        },
        "title": "Pyridostigmine in the management of orthostatic hypotension: a systematic review and meta-analysis",
        "description": "Background Current pharmacological approaches for the treatment of orthostatic hypotension (OH) may detrimentally affect supine blood pressure (BP). This side effect is often unacceptable and limits t..."
      }
    },
    "langs": [
      "de"
    ],
    "facets": [
      {
        "index": {
          "byteEnd": 176,
          "byteStart": 170
        },
        "features": [
          {
            "tag": "MECFS",
            "$type": "app.bsky.richtext.facet#tag"
          }
        ]
      },
      {
        "index": {
          "byteEnd": 281,
          "byteStart": 248
        },
        "features": [
          {
            "uri": "https://openheart.bmj.com/content/12/1/e003106",
            "$type": "app.bsky.richtext.facet#link"
          }
        ]
      }
    ],
    "createdAt": "2025-04-17T17:57:51.241Z"
  }
}